Medicamen Biotech Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Shivalik Rasayan limited, was filed 23 Mar 2024.
Medicamen Biotech Limited: what insiders have been doing
Every trade that managers of Medicamen Biotech Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 24 October 2026, 1 filing were filed, from 1 insider.
Only sales appear on the open market, 1 sale in all totalling €97k, filed by 1 insider. Sanjay Bansal filed the largest sale, €97k, on 30 September 2026.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 1,891 companies tracked on its exchange, the median is 4 filings; at 1 filing, this issuer sits below that mark. Our records for Medicamen Biotech Limited go back to 2021, with 6 purchases and 17 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +19.4%Entry ₹401.00 · Close at T+365 ₹478.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 32,813 shares@ ₹321.30100.0% of flowEquityMarket SaleSEBI:426d654f08056ce8ba2cffa22b7b95bb32d04fdd
- 100,000 sharesEquity SharesSEBI:46ef7f2ca966032429d45c626bda88969fac6944
- 3,000 shares@ ₹448.656.3% of flowEquity SharesSEBI:03ae1494ae1e942f1550e3814e08687c93e5ca7f
- 2,000 shares@ ₹572.29155.4% of flowEquity SharesSEBI:75380eb3e08bbc8e82895d537738a96f3d3e0555
- 313 shares@ ₹612.16610.9% of flowEquity SharesSEBI:c088517c60fbbd6042c9908366fc2769c1440819
- 1,490 shares@ ₹475.86383.2% of flowEquity SharesSEBI:e87d9f5964ab4333489e7f66b0cfa88dfceacbd4
- 1,000 shares@ ₹398.1981.8% of flowEquity SharesSEBI:10487fbbda72fdf1d88a1d10692dc691829676e9
- 2,449 shares@ ₹428.06944.9% of flowEquity SharesSEBI:01b40109a1942df3f84708f9a470956d77770510
- 200,000 shares@ ₹424.355100.0% of flowEquity SharesSEBI:3686d1ca53547736e4b8f918aa9f47372a1105d4Canonical exit: 20 Jun 2024 (T+90)
- 200,000 shares@ ₹419.430434.2% of flowEquity SharesSEBI:cf611a986f5f0077bc078a7b90a2385542745d94
- 28,100 shares@ ₹383.965150.0% of flowEquity SharesSEBI:d6e5f67378973af2252ca3559a0890cc46b57302
- 5,531 shares@ ₹462.594811.9% of flowEquity SharesSEBI:279240505f71d28e1c9bc6cf6156ad0571fd9085
- 2,800 shares@ ₹486.00866.4% of flowEquity SharesSEBI:34412450d06da1768a4160863e5d259f0b63ce09
- 73,370 shares@ ₹27.23179.3% of flowEquity SharesSEBI:1a483b09d999a68a1f3b150f41126eb7553c3f33
- 24,990 shares@ ₹904.94939.9% of flowEquity SharesSEBI:0240b81287c4e8e268a0ea2a98777ed22beac1b2
- 29,000 shares@ ₹940.057311.9% of flowEquity SharesSEBI:db59e2688c7f669190a3a32e88a48c1b25e6bd64
- 46,010 shares@ ₹987.708319.8% of flowEquity SharesSEBI:eac8d6b07ca417c489efd032f7ada710f9076868
- 1,576 shares@ ₹815.36740.6% of flowEquity SharesSEBI:09af3d241295ee6d83fa7bf42ba1a55cdf032f76
- 200 shares@ ₹758.2951.0% of flowEquity SharesSEBI:93dd9972e5adb2e5221d65365331f0e9051de2cbCanonical exit: 20 Mar 2022 (T+90)
- 7,468 shares@ ₹832.42192.7% of flowEquity SharesSEBI:7e3f57f7b188f909e664545a54e181bde0150091
- 100 shares@ ₹776.900.5% of flowEquity SharesSEBI:327a6b71ce7e88ca16f431fcabcb3d450a80a0d5Canonical exit: 17 Mar 2022 (T+90)
- 7,084 shares@ ₹723.573532.9% of flowEquity SharesSEBI:3b38db47410af300cc3d21486165fca8721fc818Canonical exit: 14 Mar 2022 (T+90)
- 23,475 shares@ ₹793.22948.0% of flowEquity SharesSEBI:2b407e17fa5a8f9375045c67d8f983abe74942ab
- 10,218 shares@ ₹757.170749.7% of flowEquity SharesSEBI:e4c1d84ada3b09c037f559d192f81d42d801d02cCanonical exit: 10 Mar 2022 (T+90)
- 20,500 shares@ ₹953.46748.4% of flowEquity SharesSEBI:22018b314c20cfe920a6686d7f878ae7a0b411fe
25 of 27 declarations
About Medicamen Biotech Limited
Medicamen Biotech Limited is an Indian company specializing in the manufacturing of pharmaceutical products. It operates in the healthcare and pharmaceutical sector, listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
